Suppression of Osteosarcoma Cell Invasion by Chemotherapy Is Mediated by Urokinase Plasminogen Activator Activity via Up-Regulation of EGR1
2011

Chemotherapy Helps Prevent Osteosarcoma Cell Invasion

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Matsunoshita Yukihiro, Ijiri Kosei, Ishidou Yasuhiro, Nagano Satoshi, Yamamoto Takuya, Nagao Hiroko, Komiya Setsuro, Setoguchi Takao

Primary Institution: Kagoshima University, Kagoshima, Japan

Hypothesis

Does chemotherapy affect the expression and function of EGR1 in osteosarcoma cells?

Conclusion

Chemotherapy prevents osteosarcoma cell invasion by down-regulating urokinase plasminogen activity via up-regulation of EGR1.

Supporting Evidence

  • EGR1 expression was down-regulated in osteosarcoma cell lines and biopsy specimens.
  • Chemotherapy increased EGR1 expression in both cell lines and patient specimens.
  • Forced expression of EGR1 reduced osteosarcoma cell invasion in vitro.
  • EGR1 down-regulated urokinase plasminogen activator and its receptor.
  • In vivo studies showed reduced metastasis in EGR1-expressing cells.

Takeaway

Chemotherapy can help stop cancer cells from spreading, even if it doesn't stop them from growing.

Methodology

The study involved real-time PCR, MTT assays, and xenograft models to assess EGR1 expression and osteosarcoma cell behavior.

Limitations

The study primarily focused on in vitro and murine models, which may not fully replicate human responses.

Participant Demographics

Patients with osteosarcoma, including those receiving chemotherapy.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016234

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication